Mapping temporal order of whole brain volumetric changes using change point analysis in premanifest Hungtington Disease
Dan Wu1, Laurent Younes2,3,4, Andreia V Faria1, Christopher A Ross5, Susumu Mori1,6, and Michael I Miller3,4,7

1Radiology, Johns Hopkins University School of Medicine, BALTIMORE, MD, United States, 2Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, United States, 3Center for Imaging Science, Johns Hopkins University, Baltimore, MD, United States, 4Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, United States, 5Departments of Psychiatry, Neurology, Neuroscience and Pharmacology, and Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, BALTIMORE, MD, United States, 6F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States, 7Biomedical Engineering, Johns Hopkins University, Baltimore, MD, United States

Synopsis

In order to understand the temporal and spatial order of brain atrophy in Huntington’s disease (HD), we aim to characterize the whole brain volumetric changes based on T1-weighted whole brain segmentation. We adapted a novel multi-variant linear statistical model to capture the change points of volumetric changing courses from 412 control and HD subjects. The change point analysis revealed that the brain atrophy initiated in the deep gray matter structures and progressed to the peripheral white matter and cortical regions, and it also suggested the posterior brain atrophy proceeded the anterior brain.

Introduction

Huntington’s disease (HD) is a neurodegenerative disorder that progressively affects motor and cognitive functions. It is known that the disease is caused by CAG repeat expansion in the gene Hungtingtin (HTT), and is directly related to the CAG-age product (CAP score)1,2. Previous MRI studies have shown structural degeneration in basal ganglia and a range of grey and white matter structures3,4. However, the spatial and temporal order of the structural changes is not fully understood. In this study, we adapted a novel statistic model, namely the change point analysis5, to capture the critical turning points of brain volumes against disease progression, based on whole brain parcellation of T1-weighted images.

Methods

The data used in this study are from the multicenter PREDICT-HD study4,6,7. MPRAGE data from 412 subjects were used, including 121 controls and 291 premanifest HD with CAP score ranged 140-586. The image were acquired around 1×1×1.5 mm3 resolution with heterogeneous protocols4. The images were segmented using our online resource MriCloud8,9 (www.mricloud.org), which provides a fully automated T1 segmentation pipeline based on diffeomorphic image registration and multi-atlas fusion10,11.

A two-step multivariant linear statistical model was established to examine volumetric changes in relation to the CAP score, which is a reliable indicator of the disease severity and reflects the temporal order. In the first step, the group difference between the HD subjects and controls is estimated based on the group label (g, 1 for HD and 0 for control), CAP score (c), age (a), sex (s), and intracranial volume (i).

Model 1: $$$y_{j}=\alpha+\beta\cdot c_{j}\cdot g_{j}+\gamma\cdot g_{j}+\delta\cdot a_{j}+\eta\cdot s_{j}+\lambda\cdot i_{j}+\epsilon_{j}$$$

where y denotes the volume, j is the subject index, α is a constant, and ε is the noise. The model parameters [α, β, γ, δ, η, λ] are estimated using maximum likelihood estimation. A group difference is detected when β ≠ 0 and γ ≠ 0. In the second step, only the HD population is involved, and the change point is modeled as an additional linear change that takes effect when CAP score is greater than the change point Δ, in addition to the baseline change.

Model 2: $$$y_{j}=\alpha+\beta\cdot c_{j}+\beta^{'}\cdot c_{j}\cdot H(c_{j}-\triangle)+\eta\cdot s_{j}+\lambda\cdot i_{j}+\epsilon_{j}$$$

where H is a Heaviside function such that H(t) = 1 if t>0 and H(t) = 0 otherwise. The optimal change point is obtained at Δ* when the likelihood L(Δ*) is maximal among all Δs between 200-500. A significant change point is found when β’ ≠ 0 at Δ*. The significance is evaluated by permutation test12, and the variance of the change point is estimated via bootstrap5.

Results

Figure 1 showed the change points detected in several key structures that had significant volumetric reduction as the CAP score increased. The volumes were represented as the percentage differences with respect to the controls. Note that, if a significant group difference is detected from model 1 but no significant change point is detected from model 2, we assume a linear change with CAP and assign the earliest change point (Δ*=150, in unit of CAP) for that structure, such as the basal ganglia. We mapped the change points with familywise significance of p<0.05 onto a T1-weighted brain template in Figure 2. The map revealed the earliest volumetric changes in the basal ganglia and ventricle, followed by the white matter and then the occipital and frontal cortices, while the posterior white matter changed ahead of the anterior white matter. Figure 3 showed the rate of percentage volume change after the change point, which suggested a rapid volume loss in the basal ganglia and a drastic expansion in ventricle. In addition, the anterior brain structures showed a relatively faster atrophy compared to the posterior brain.

Discussion and Conclusion

While much is known about HD and its MRI markers at discrete time points and individual structures, in this study, we mapped the spatiotemporal changing pattern of whole brain atrophy using a novel statistical model. Our findings agree with the general understanding of injury progression from the deep gray matter to the white matter and then to the cortical regions. At the same time, the data suggest a posterior-to-anterior gradient, where the posterior brain structures change earlier but at a relatively slow rate and vice versa in the anterior brain. Although the data we used in this study are not longitudinal, this large population of cross-sectional data analysis provides important knowledge about the temporal order of disease progression. In addition to the volumetric analysis, measurements from diffusion MRI or other imaging contrasts could provide more sensitive markers, and a multi-modality study is undergoing.

Acknowledgements

No acknowledgement found.

References

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971-983.

2. Penney B, Vonsattel P, MacDonald E, et al. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol. 1997;41:689-692.

3. Ross C, Aylward E, Wild E, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10:204-216.

4. Paulsen S, Nopoulos C, Aylward E, et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull. 2010;82:201-207.

5. Younes L, Albert M, Miller M. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. NeuroImage Clin. 2014;5:178-187.

6. Paulsen S, Long D, Johnson J, et al. Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICTHD Study. Front Aging Neurosci. 2014;6:78.

7. Paulsen S, Long D, Ross A, et al. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study. Lancet Neurol. 2014;13:1193-1201.

8. Djamanakova A, Tang X, Li X, et al. Tools for multiple granularity analysis of brain MRI data for individualized image analysis. Neuroimage. 2014;101:168-176.

9. Wu D, Ma T, Ceritoglu C, et al. Resource atlases for multi-atlas brain segmentations with multiple ontology levels based on T1-weighted MRI. Neuroimage. 2014; doi:10.1016/j.neuroimage.2015.10.042.

10. Tang X, Oishi K, Faria AV, et al. Bayesian Parameter Estimation and Segmentation in the Multi-Atlas Random Orbit Model. PLoS One. 2013;8:e65591.

11. Hongzhi W, Suh W, Das R, et al, Multi-Atlas Segmentation with Joint Label Fusion. IEEE Trans Pattern Anal Mach Intell. 2013;35(3):611-23.

12. Nichols T and Hayasaka S. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat Methods Med Res. 2003;12(5):419-446

Figures

Figure 1: Change point analysis in the major gray and white matter structures. The blue dots represent the volumetric measurements (in unit percentage differences compared to the controls); the yellow dots represent the fitted data based on model 2; the black curves are the sigmoid fitting to the measurements; and the red lines indicate the change points. The p-values and the standard deviations of the change points are denoted in each graph.

Figure 2: Change points of the whole brain structures mapped to a T1-weighted image in coronal, axial, and sagittal views. The colorbar indicates the change points in unit of CAP score.

Figure 3: Change rates of the structural volumes after the change points, mapped to a T1-weighted image. The change rate are calculated as the percentage volumetric difference per CAP score. Warm color indicates volume expansion in the ventricles and sulci, and the cold color indicates volume loss in white and grey matter stuctures.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0686